ndothelial nitric oxide synthase (eNOS) plays a crucial role in the maintenance of systemic as well as cerebral hemodynamics. 1 The regulation of the constitutive eNOS and neuronal NOS gene expression is relatively stringent. We recently reported that some of the biological effects of prostaglandins, specifically prostaglandin E 2 (PGE 2 ), involve the induction of eNOS in cerebral microvascular endothelium and are mediated distinctly via EP 3 receptors; 2 this effect of PGE 2 operates in the mature and the developing subject where it may be instrumental in controlling oxygenation of neuronal tissues. 3 The biological actions of prostaglandins have been attributed to their interaction with cell surface G protein-coupled receptors. However, circumstantial evidence supports the idea that prostaglandins, either formed within the cell or captured from extracellular space, may also act intracellularly. For example, the enzymes involved in the biosynthesis of prostaglandins, namely COX-1, COX-2, and PLA 2 , have been found to be localized at the nuclear envelope of different cell types. 4, 5 A specific prostaglandin transporter that facilitates the influx of prostaglandins has also been identified. 6, 7 More importantly, in addition to plasma membrane EP 3 receptors, presence of functional perinuclear EP 3 receptors for PGE 2 has been demonstrated in a variety of cells such as cerebral microvascular ECs, Swiss 3T3 cells, and host cells HEK293. 8, 9 Genomic effects of PGE 2 through its perinuclear receptor, notably on highly inducible genes such as mitogenic transcription factor c-fos and iNOS, have been recently reported. 8, 9 However, the regulation of constitutive genes, such as eNOS by PGE 2 acting through perinuclear receptors, has never been shown. Such a conjecture can be further extended with regards to the relative contribution of plasma membrane G protein-coupled receptors versus their perinuclear counterparts in the regulation of cellular physiological events.
Because COX-2 localizes principally to the nuclear envelope 4 and this enzyme plays a dominant role in prostaglandin production in brain microvasculature in early postnatal development, 10 one could speculate that in the presence of functional intracellular prostaglandin receptors, PGE 2 -induced upregulation of eNOS gene might involve EP 3 receptors localized intracellularly, specifically at the cell nucleus. 2 The present study was undertaken to test the hypothesis that PGE 2 receptor EP 3 on nuclear envelope exhibits different functions from those on plasma membrane, such that PGE 2 -induced eNOS expression is largely mediated by activation of nuclear EP 3 receptors in brain microvascular ECs. Our findings support this hypothesis and reveal that PGE 2 -induced eNOS expression is mediated by a pertussis toxin-sensitive EP 3 , which involves activation of Ca 2ϩ -dependent K ϩ channels (K Ca ), phosphatidylinositol 3-kinase (PI-3 kinase), MAP kinase kinase (MEK), and NF-B pathways.
Material and Methods

Chemicals
M&B28767 was a gift from Rhone-Poulenc Rorer, Dagenham Essex, UK; EP 3␣ antibody was a gift of Dr H. Shichi (Kresge Eye Institute, Detroit, Mich); and human EP 3␣ cDNA was obtained from Merck (Pointe-Claire, Québec, Canada). The following agents were purchased: 16,16-dimethyl-PGE 2 , U46619, sulprostone, and 17-phenyl trinor-PGE 2 (Cayman); ibuprofen, glibenclamide, soybean trypsin inhibitor, bromcresol green, bromosulfophthalein, substance P, arachidonic acid, phenylmethylsulfonyl fluoride, actinomycin D, 3-aminopropyltriethoxysilane, 17␤-estradiol, Nonidet P-40, and pyrrolidine dithiocarbamate (PDTC) (Sigma); iberiotoxin, cromakalim, EGTA, pertussis toxin (PTX), fura-2-AM, BAPTA-AM, wortmannin, and PD 98059 (Calbiochem); SK&F96365, methylcarbamylplatelet-activating factor (C-PAF) ( 
Animals
Experiments were performed on cells from brain microvasculature from Yorkshire piglets (L'Ange Gardien, Québec, Canada) anesthetized with halothane (2%) and euthanized with intracardiac pentobarbital (120 mg/kg) in accordance with regulations of the Canadian Council of Animal Care Committee and approval of the SainteJustine Hospital Animal Care Committee.
Cell Culture and Transfection
Cerebral microvessels were isolated and primary EC cultures established as previously described. 2, 11 ECs from passages 5 to 13 were used in the present study. The full-length human EP 3␣ receptor cDNA was subcloned into the pCMV-Tag2 vector downstream to the FLAG epitope; framing and orientation were confirmed by sequencing of the construct. Positioning of the small FLAG epitope at the N-terminus does not alter ligand-induced function 12 (see Results). ECs (60% confluence) grown on glass coverslips were transfected with the plasmid using the FuGENE 6 Transfection Reagent (Roche) or PolyFect (Qiagen) according to manufacturer's instructions.
Cell Fractionation and Nuclear Isolation
Cell fractionation was achieved by the hypotonic/Nonidet P-40 lysis method. Briefly, ECs were washed 3 times with ice-cold PBS, gently scraped, and pelleted at 500g for 5 minutes. The cell pellet (for Ϸ50ϫ10 6 cells as starting material) was resuspended in 2 mL lysis buffer (10 mmol/L Trizma/Base, pH 7.4, 10 mmol/L NaCl, 3 mmol/L MgCl 2 , 100 g/mL soybean trypsin inhibitor, and 1 mmol/L phenylmethylsulfonyl fluoride [PMSF]), homogenized (100 gentle strokes) with a Dounce tissue grinder (tight pestle; Bellco Glass), and then centrifuged at 600g for 10 minutes at 4°C. The pellet was resuspended in 2 mL lysis buffer containing 0.1% (v/v) NP-40, left on ice for 5 to 10 minutes and sedimented thereafter at 600g for 10 minutes at 4°C. Nuclear pellet was washed 3 times with 10-mL lysis buffer. The morphological integrity and purity (Ͼ98%) was assessed by light microscopy after trypan blue staining and by electron microscopy ( Figure 1) . Essentially, isolated nuclei were fixed for 4 hours at 4°C in Tris-HCl buffer (50 mmol/L) pH 7.0 containing 3% glutaraldehyde, MgCl 2 (5 mmol/L), and sucrose (250 mmol/L). Samples were then washed, fixed with osmium tetroxide (1%), dehydrated with ethyl alcohol, and embedded in Epon. Ultrathin sections were examined using a transmission electron microscope (Philips 410 LS). The nuclear fraction contained Ͻ7% of the total cellular activity of plasma membrane marker 5Ј nucleotidase (Sigma assay kit). 
Gene Transcription Assays and Detection of eNOS RNA
Porcine primary cerebral ECs (80% confluence) were incubated for 18 hours in Dulbecco's modified Eagle's medium in the absence or presence of the following agents: ibuprofen (10 mol/L), 16,16 dimethyl PGE 2 (1 mol/L, stable PGE 2 analog), prostaglandin transporter inhibitor bromcresol green (50 mol/L), 6, 13 and/or selective EP 3 agonist M&B28767 (1 mol/L). 14 Ribonuclease protection assays were performed to detect eNOS and destrin (control) mRNA as previously described. 2, 15 For experiments using isolated nucleus, eNOS and 18S nuclear RNA was quantified by reverse transcriptase-polymerase chain reaction (RT-PCR) method as utilized. 15 For this purpose, isolated nuclei (200 g protein, 50 L) were placed in buffer of the following composition: Tris-HCl (10 mmol/L; pH 7.4), KCl (135 mmol/L), MgCl 2 (3 mmol/L), CaCl 2 (100 nmol/L), ATP, UTP, GTP, and CTP (500 mol/L), and RNase guard (100 U). Nuclei were incubated at 37°C for 60 minutes with saline or 17-phenyl trinor-
in the presence of membrane permeable and impermeable Ca 2ϩ chelators EGTA (100 mol/L) and BAPTA-AM (100 mol/L), preactivated PTX (20 g/mL, 60 minutes preincubation), 9 nonspecific receptor-operated Ca 2ϩ channel blocker SK&F96365 (10 mol/L),
, or with NF-B binding inhibitor PDTC (100 mol/L). 16 Total RNA was purified by standard guanidine isothiocyanate method and subjected to RT-PCR for eNOS and 18S RNA detection using methods and primers reported. 2, 15 
Effect of EP 3 Receptor Agonist M&B28767 on NO-Dependent Vasorelaxation of Cerebral Microvessels
To assess whether modulation of M&B28767-induced eNOS expression by prostaglandin transporter inhibitor bromcresol green was reflected into function, vasorelaxation to eNOS-dependent substance P was studied 17 on cerebral microvessels in situ using video-imaging technique. 2, 15 
Western Blot of MAP Kinases and Akt Activation
Isolated nuclei (100 g protein) from ECs were treated or not with M&B28767 (0.1 mol/L) for 0 and 15 minutes in the abovementioned buffer. Freezing samples in liquid N 2 terminated the reaction. Proteins were resolved by SDS-PAGE on 9% gel, transferred onto PVDF membranes, and then probed in immunoblots with Erk, phospho-Erk (1/2), Akt, and phospho-Akt antibodies (diluted 1:1000) according to manufacturer's instructions. Autoradiograms were scanned and analyzed by densitometry (ImagePro 4ϩ software).
Detection of EP 3 Receptors and K Ca Channels
EP 3 receptors and BK Ca channels were immunodetected on ECs and derived isolated nuclei as described 8, 9 ; immunogold technique for EP 3 was used as reported. 8 Briefly, after fixation, cells and nuclei were incubated for 1 hour with appropriate antibody diluted in PBS containing 5% goat serum and 5% fetal calf serum. Fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit or Texas Redconjugated donkey anti-rabbit IgG was used as the secondary antibody (1:200 dilution) (Santa Cruz Biotechnology). In separate experiments, omission of primary antibodies was used as negative controls. Nuclei were stained with propidium iodide (PI; 3 ng/mL) or Sytox green (100 nmol/L). Samples were then mounted on slides with fluoroguard solution (Bio-Rad) and analyzed with fluorescent microscope (Zeiss) or a Multi Probe 2001 confocal argon laser scanning system (Molecular Dynamics). In other experiments, [ 3 H]PGE 2 binding and displacement by specific EP ligands was performed as described. 8
Measurement of Calcium Signals and Potentiometric Changes in Nuclei
Nuclear calcium [Ca 2ϩ ] signals were measured by fura-2-acetoxymethyl ester technique as described. 8, 9 The fluorescent potentiometric styryl dye RH421 was used to ascertain change of nuclear membrane potential and fluorescence was measured as reported. 18 Nuclei were placed in HEPES/Tris (20 mmol/L, pH 7.0) containing CaCl 2 (10 nmol/L), sucrose (300 mmol/L), and either 100 mmol/L K 2 SO 4 or 1 mmol/L K 2 SO 4 . Nuclei were stimulated with NS1619 or with M&B28767 with or without iberiotoxin. Excitation and emission wavelengths were 475 nm and 645 nm, respectively.
cAMP and Inositol 1,4,5-Triphosphates (IP 3 ) Assays
Membrane preparations (200 g protein) were incubated in the absence or presence of M&B28767 (0.1 mol/L), 11, 19 and cAMP and inositol 1,4,5-triphosphates (IP 3 ) generation was measured on nuclear and plasma membranes as described. 11 
Statistical Analysis
Data were analyzed by 1-way ANOVA factoring for treatments with the exception of vasomotor responses, which were analyzed by 2-way ANOVA factoring for concentration and treatment groups.
Comparison among means was performed by Tukey-Kramer method. Statistical significance was set at PϽ0.05. Data are presented as meanϮSEM.
Results
Intracellular Role of PGE 2 in Regulation of eNOS Expression
Inhibition of endogenous prostaglandin formation with ibuprofen (12 to 18 hours) caused a marked reduction of eNOS mRNA in microvascular ECs (Figure 2A ). Concurrent treatment with stable PGE 2 analog 16,16-dimethyl PGE 2 or selective EP 3 agonist M&B28767 prevented the effect of ibuprofen, as documented. 2 Prostaglandin transporter inhibitor bromcresol green prevented 16,16-dimethyl PGE 2 -and M&B28767-induced upregulation of eNOS expression; comparable effects were observed with a distinct prostaglandin transporter inhibitor, bromosulfophthalein (100 mol/L). 6 These prostaglandin transporter inhibitors per se had no effect on eNOS mRNA expression. Data suggest that PGE 2 and analogs do not seem to induce eNOS mRNA expression by activating the readily accessible plasma membrane EP 3 receptor but rather requires intracellular transport for this purpose.
To test whether the effect of PGE 2 analogs on eNOS expression modulated by prostaglandin transporter inhibitors is reflected functionally, we exposed porcine brain slices to M&B28767 (4 to 6 hours) and measured the NO-dependent vasorelaxant responses of microvessels to substance P. Substance P-induced vasorelaxation, which as anticipated could be fully inhibited by the NOS blocker L-nitro-arginine (L-NA) (1 mmol/L), was augmented in tissues incubated with M&B28767 ( Figure 2B ). This enhanced vasorelaxation to substance P was prevented by concomitant treatment (4 to 6 hours) with bromcresol green or transcription inhibitor actinomycin D; treatment simply with bromcresol green (without M&B28767) did not alter vasorelaxation to substance P. In contrast, treatment with bromcresol green or actinomycin D did not interfere with vasoconstriction to M&B28767 ( Figure  2C) ; M&B28767 does not evoke relaxation of brain parenchymal vessels. 19 Hence, findings imply distinct functions for intracellular and plasma membrane EP 3 receptors, such that the former induces eNOS expression and the latter mediates vasoconstriction.
Nuclear Immunolocalization of EP 3 Receptors and Their Effect on eNOS Expression
We investigated if direct stimulation of nuclear EP 3 receptors can elicit eNOS expression. EP 3 immunoreactivity on plasma membrane and perinuclear region of ECs was confirmed ( Figures 3A and 3B ) and similarly shown on isolated nuclei ( Figure 3C) ; furthermore, high-resolution electron microscopy revealed dominance of EP 3 more specifically on the outer nuclear membrane ( Figure 3A) . Stimulation with M&B28767 elicited eNOS RNA expression in isolated nuclei ( Figure 3E ). Similar results were obtained using sulprostone, an EP 1 /EP 3 receptor agonist, whereas the EP 1 selective agonist 17-phenyl trinor-PGE 2 was ineffective.
To further establish that the effect of M&B28767 was specifically dependent on stimulation of EP 3 receptors, this effect was tested on nuclei of ECs in which we overexpressed EP 3 by transfection with a cDNA of EP 3␣ fused to FLAG ( Figure 3D) ; nontransfected cells do not exhibit immunoreactivity to FLAG (not shown). Nuclear eNOS expression induced by M&B28767 (0.1 mol/L) was significantly enhanced in transfected cells ( Figure 3E) ; unrelated lipid, platelet-activating factor was ineffective. In addition, on ECs from pulmonary artery where EP 3 receptor binding sites were not detectable, but which do contain the other 3 EP receptors, M&B28767 did not induce upregulation of eNOS RNA as opposed to the well known eNOS inducer 17␤-estradiol (10 nmol/L), 20 which caused a 65Ϯ5% increase in eNOS RNA.
Effect of EP 3 Stimulation on Nuclear Ca
2؉
Transients and eNOS Transcription: Role for G Proteins, K Ca Channels, and Kinases PTX inhibited nuclear eNOS expression evoked by EP 3 agonist M&B28767, suggesting coupling to Gi/o ( Figure 4A ). Despite presence of functional phospholipase C and adenylate cyclase at the nuclear membrane, 21,22 EP 3 stimulation did not reduce cAMP generation induced by forskolin or elicit IP 3 formation, whereas on plasma membrane, M&B28767 decreased net forskolin-induced cAMP formation (from 39Ϯ3 to 30Ϯ2 pmol/mg protein/min, PϽ0.05). Because G protein signaling can occur through Ca 2ϩ channels 23 and nuclear Ca 2ϩ participates in controlling gene transcription, 24 we investigated if changes in nuclear Ca 2ϩ can be elicited by EP 3 stimulation. Incubation of isolated nuclei from ECs with M&B28767 induced a concentration-dependent increase in nuclear Ca 2ϩ levels ( Figure 4B ). Ca 2ϩ chelators EGTA and BAPTA and nonspecific Ca 2ϩ channel blocker SK&F96365 prevented M&B28767-induced Ca 2ϩ transients and induction of eNOS RNA, as seen with PTX ( Figures 4A and 4B) .
Upregulation of eNOS gene expression by PI-3 kinase/Akt and MEK-1-dependent pathways has recently been reported in human ECs. 25 These protein kinases have been localized in the nucleus where they can regulate binding of transcription factors onto promoter regions of targeted genes. 24, 25, 26 Our findings show phosphorylation (and resultant activation) of Akt and Erk1/2 by direct treatment of nuclei with M&B28767 and suppression of eNOS gene with PI-3 kinase-activated protein kinase Akt 27 and MEK inhibitors wortmannin and PD98059, respectively ( Figure 4A) ; NF-B binding inhibitor PDTC also prevented M&B28767-induced eNOS expression.
We also tested if EP 3 -induced Ca 2ϩ transients can be elicited by opening ion channels 23 identified at the nuclear envelope. 28 We focused on K ϩ channels because (1) they are present in endothelium including of neurovascular tissue, 15 (2) their activation can lead to Ca 2ϩ transients in ECs, and (3) they have been detected at the nuclear membrane. 28 Isolated nuclei of neurovascular ECs exhibited perinuclear immunostaining to BK Ca detected by confocal microscopy imaging ( Figure 5A ). On nuclei, K Ca channel opener NS1619 stimulated Ca 2ϩ transients and potentiometric changes (in high K ϩ buffer) detected with the styryl dye RH421 ( Figures 5B and  5C ); these signals were inhibited by iberiotoxin. EP 3 stimulation induced nuclear Ca 2ϩ transients, fluorescence-detected potentiometric changes, and nuclear eNOS expression, which were all prevented by iberiotoxin but not by K ATP blocker glibenclamide (Figures 4 and 5C ).
Discussion
The present study was intended to determine the cellular site of action of PGE 2 in regulating eNOS expression in brain microvascular ECs. In this process, we have unveiled a previously undescribed concept for the G protein-coupled receptor EP 3 , which exhibits on the nuclear envelope functions that are different from those on plasma membrane. We have provided direct evidence that stimulation of the perinu- clear EP 3 receptor can induce the expression of a constitutive gene, namely eNOS. This EP 3 induction of eNOS expression is coupled to a BK Ca channel, formerly never shown in nuclear envelope of ECs.
Evidence for perinuclear G protein-coupled receptors is accumulating. Receptors for PTH, endothelin, angiotensin II, opioids, and prostanoids have been found at the perinuclear membrane. 8,9,29 -31 Physiological relevance of perinuclear prostanoid receptors is strengthened by localization of ligandgenerating enzymes, namely cPLA 2 , COX-1, and COX-2, in the vicinity of receptor sites at the nuclear envelope. 4, 5 Furthermore, functionality of perinuclear G protein-coupled receptors has only been described for PGE 2 receptors including EP 3 , which was reported to evoke immediately early gene transcription. 8, 9 The present findings extend the scope of nuclear EP 3 actions to include the regulation of constitutive genes, namely of eNOS.
A major feature of this study is the suggestion for different roles for EP 3 receptors on nuclear envelope and plasma membrane. This inference is supported by a number of observations. (1) The presence of EP 3 receptors on plasma and nuclear membranes of brain ECs has previously been documented by binding and immunoreactivity 9 ; these observations have been substantiated ( Figure 3A) . (2) Effects of ibuprofen on eNOS expression in ECs imply a role for endogenous prostaglandins; accordingly, an inhibitable net synthesis of PGE 2 (1.8Ϯ0.4 pg/mg protein/min) by nuclear membranes was observed during incubation with arachidonic acid (1 mol/L). Inhibition of endogenous prostaglandins with ibuprofen allowed to investigate the effects of exogenous PGE 2 analogs on eNOS expression, which were reversed by PGE 2 and selective EP 3 agonist M&B28767. 14 But prostaglandin transporter inhibitor bromcresol green (and bromosulfophthalein) prevented the PGE 2 -and M&B28767-induced increase of eNOS expression and associated NO-dependent relaxation to substance P (Figure 2) . The prostaglandin transporter is present on ECs. 32 The transporter inhibitors utilized block uptake of prostaglandins into cells but per se do not interfere with prostanoid receptor-mediated events 7, 13 or with eNOS expression (Figures 2A through 2C) . (3) Vasoconstrictor effects evoked by direct stimulation of EP 3 receptors were unaltered by prostaglandin transporter inhibitors ( Figure 2C ), suggesting effects on plasma membrane receptors. 11 (4) EP 3 receptors on nuclear envelope and plasma membrane are coupled to different signals: adenylate cyclase in the latter but not in the former. (5) More convincingly, a role for nuclear EP 3 receptors in inducing eNOS expression was obtained by direct stimulation of isolated nuclei from ECs with the EP 3 agonist M&B28767; as anticipated from the receptor occupancy theory, these effects were augmented by overexpressing the EP 3 receptor ( Figure 3D ). Collectively, these findings suggest a major role for perinuclear EP 3 receptors in the regulation of eNOS expression, which seems distinct from actions mediated by plasma membrane EP 3 .
The nucleus is a dynamic calcium and ion barrier 28 ; in the unstimulated state, our nuclear preparations exhibited stable Ca 2ϩ concentrations and potentiometry ( Figure 5 ). Nuclear calcium plays an instrumental role in DNA repair, chromatin condensation and regulation of gene transcription. 24 A number of Ca 2ϩ channels and pumps have been identified on the nuclear envelope. IP 3 , IP 4 and ryanodine receptors, and Ca 2ϩ -ATPase pump, are some of these nuclear Ca 2ϩ trafficking mechanisms. 33, 34 Our findings conform to these reports. Specifically, chelation of extranuclear and intranuclear Ca 2ϩ or blockade of Ca 2ϩ channels prevented EP 3 stimulationinduced transcription of eNOS in isolated nuclei.
It has been suggested that ion currents regulate nuclear Ca 2ϩ channels. 28 A variety of ion channels have been found localized at the nuclear envelope mostly on the outer membrane. 28 We have identified functional K Ca channels on the nuclear envelope, which are coupled to EP 3 receptors, regulate nuclear Ca 2ϩ channels, and in turn affect eNOS expression (Figures 4 and 5) . This deduction is supported by effects of K Ca channel openers on nuclear Ca 2ϩ transients and potentiometry, and more importantly by effects of selective BK Ca blockers on these parameters and eNOS expression induced by EP 3 stimulation ( Figures 4 and 5) ; of relevance, changes in nuclear membrane potential have been associated with DNA replication. 24 The actions, we observed for EP 3 mediated by BK Ca , are dependent on G protein activation but independent of cAMP and IP 3 formation. EP 3 receptors can couple to Gq and/or PTX-sensitive Gi/Go proteins. 35 This suggests that in brain vascular ECs, induction of eNOS gene by PGE 2 via EP 3 receptors seems linked to subsequent Figure 5 . A, Localization of BK Ca channels on isolated nuclei of cerebral ECs. Nuclei were immunostained for BK Ca (FITCconjugated), counterstained with PI, and visualized by confocal microscopy; in the absence of primary antibody, no staining was seen. Perinuclear localization is clearly seen, especially in the further magnified nucleus in the insert. B and C, Effect of EP 3 and K Ca channel stimulation on nuclear Ca 2ϩ transients and potentiometric changes. Ca 2ϩ transients were measured spectrofluorometrically using fura-2/AM; arrow points to moment of addition of compounds. Potentiometric changes were assessed using the styryl dye RH421 in high (100 mmol/L) and low (1 mmol/L) K ϩ buffer; iberiotoxin was used at 0.1 mol/L. Values in histogram are meanϮSEM of 3 to 4 experiments; *PϽ0.05 compared with values without asterisks.
activation of Go proteins; through their ␤/␥ subunits these G proteins may directly control ion channels 36 independently of cAMP or IP 3 . 37 In addition, this nuclear EP 3 receptor-evoked increase in eNOS expression was found to be mediated via PI-3 kinase/Akt and Erk-MAP kinase-dependent pathways and via NF-B activation (Figure 4) , providing an alternate explanation for similar finding on whole cells. 25 In line with these observations, transcription factors of the NF-B as well as AP-1 systems can be regulated by MAP and PI-3 kinases. 25, 38 These along with other factors (such as AP-2, CRE, ER, GATA-1, and SP-1) may bind onto cis elements of known consensus sequences on the human eNOS promoter. 39 Altogether the findings set forth new perspectives in elucidating the signaling of nuclear G protein-coupled receptors such as EP 3 in controlling gene expression.
In summary, the present study identifies for the first time distinct functional roles for the nuclear envelope G proteincoupled EP 3 receptor of PGE 2 from those on plasma membrane. In so doing, the data provide a mechanism for the regulation of the constitutive eNOS gene on brain microvascular cells acting via nuclear EP 3 receptors by PGE 2 , that involves formerly undescribed perinuclear K Ca channels as well as PI-3 kinase, Erk-MAP kinase, and NF-B. This concept alluding to intracrine effects of PGE 2 applies to conditions which exhibit high endogenous prostaglandin synthesis via COX-2 pathways localized at the nuclear membrane, 4,5 such as in inflammation and in the developing subject. 10, 15 
